Universal Familial Hypercholesterolemia Screening in Children

CompletedOBSERVATIONAL
Enrollment

17,000

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

August 1, 2020

Study Completion Date

December 31, 2021

Conditions
Familial HypercholesterolemiaPolygenic Hypercholesterolaemia
Interventions
DIAGNOSTIC_TEST

Genetic analysis

After obtaining written consent from patients, DNA is isolated, and genetic analysis of the know familial hypercholesterolemia disease-causing genes (LDLR, APOB, PCSK9) is performed.

DIAGNOSTIC_TEST

Lipid levels measurement

Measurements of lipid levels (total cholesterol, LDL-cholesterol, HDL-cholesterol, TG) using standard methods.

Trial Locations (2)

1000

UMC - University Children's Hospital Ljubljana, Ljubljana

30173

Children's Hospital AUF DER BULT, Hanover

All Listed Sponsors
collaborator

University Medical Centre Ljubljana

OTHER

collaborator

Kinderkrankenhaus auf der Bult

OTHER

lead

University of Ljubljana, Faculty of Medicine

OTHER

NCT04507984 - Universal Familial Hypercholesterolemia Screening in Children | Biotech Hunter | Biotech Hunter